Baxter International Inc. (BAX) PE Ratio: N/A
The P/E ratio for Baxter International Inc. (BAX) is N/A as of Thursday, June 11, 2026.
BAX PE Ratio Chart
BAX Average PE Ratio Chart
BAX PE Ratio Metrics
PE RATIO
N/A
PE RATIO AVG TTM
44.53
PE RATIO AVG 3Y
34.41
PE RATIO AVG 5Y
37.43
PE RATIO AVG 10Y
29.51
PE RATIO AVG 15Y
22.12
PE RATIO AVG 20Y
19.92
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
BAX Competitors' PE Ratio
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Baxter International Inc. (BAX) | $10.58B | N/A | 44.53 | 34.41 | 37.43 |
| Charles River Laboratories International, Inc. (CRL) | $9.06B | N/A | 225.66 | 91.39 | 72.20 |
| Tempus AI, Inc. (TEM) | $8.65B | N/A | N/A | N/A | N/A |
| Align Technology, Inc. (ALGN) | $12.64B | 29.62 | 29.27 | 42.85 | 47.76 |
| Bio-Rad Laboratories, Inc. (BIO) | $7.91B | 48.18 | 23.82 | 23.82 | 12.07 |
| Solventum Corporation (SOLV) | $13.72B | 9.70 | 18.87 | 17.07 | 17.07 |
| Hims & Hers Health, Inc. (HIMS) | $6.44B | N/A | 61.96 | 88.48 | 88.48 |
| Hologic, Inc. (HOLX) | $16.97B | 31.67 | 28.12 | 30.08 | 22.83 |
| Moderna, Inc. (MRNA) | $19.70B | N/A | 15.46 | 32.51 | 32.51 |
| 23andMe Holding Co. (ME) | $15.31M | N/A | N/A | N/A | N/A |
P/E Comparison
Trailing P/E
N/A
Forward P/E
10.7
Forward P/E Calculation
View All Analyst EstimatesForward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$20.49
Forward EPS (Est.)
$1.92
Forward P/E
10.67
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
Baxter International Inc. PE Ratio Formula & Definition
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Baxter International Inc. PE Ratio FAQ
- What is the P/E ratio for Baxter International Inc. (BAX)?
- The P/E ratio for BAX stock is N/A.
- What is the TTM average P/E ratio for Baxter International Inc. (BAX)?
- The TTM average P/E ratio for BAX stock is 44.53.
- What is the 3Y average P/E ratio for Baxter International Inc. (BAX)?
- The 3Y average P/E ratio for BAX stock is 34.41.
- What is the 5Y average P/E ratio for Baxter International Inc. (BAX)?
- The 5Y average P/E ratio for BAX stock is 37.43.
- What is the 10Y average P/E ratio for Baxter International Inc. (BAX)?
- The 10Y average P/E ratio for BAX stock is 29.51.
- What is the 15Y average P/E ratio for Baxter International Inc. (BAX)?
- The 15Y average P/E ratio for BAX stock is 22.12.
- What is the 20Y average P/E ratio for Baxter International Inc. (BAX)?
- The 20Y average P/E ratio for BAX stock is 19.92.
Baxter International Inc. PE Ratio History
| DATE | PE RATIO |
|---|---|
| 2025-02-20 | 157.29 |
| 2025-02-19 | 144.97 |
| 2025-02-18 | 146.75 |
| 2025-02-14 | 144.97 |
| 2025-02-13 | 144.03 |
| 2025-02-12 | 142.47 |
| 2025-02-11 | 143.93 |
| 2025-02-10 | 144.92 |
| 2025-02-07 | 144.03 |
| 2025-02-06 | 144.92 |
| 2025-02-05 | 148.02 |
| 2025-02-04 | 147.79 |
| 2025-02-03 | 148.82 |
| 2025-01-31 | 153.15 |
| 2025-01-30 | 155.69 |
| 2025-01-29 | 154.19 |
| 2025-01-28 | 153.76 |
| 2025-01-27 | 157.38 |
| 2025-01-24 | 152.63 |
| 2025-01-23 | 152.63 |
| 2025-01-22 | 149.72 |
| 2025-01-21 | 148.07 |
| 2025-01-17 | 145.72 |
| 2025-01-16 | 145.58 |
| 2025-01-15 | 142.10 |
| 2025-01-14 | 144.03 |
| 2025-01-13 | 143.46 |
| 2025-01-10 | 138.38 |
| 2025-01-08 | 139.18 |
| 2025-01-07 | 139.13 |
| 2025-01-06 | 139.51 |
| 2025-01-03 | 138.76 |
| 2025-01-02 | 137.63 |
| 2024-12-31 | 137.16 |
| 2024-12-30 | 134.67 |
| 2024-12-27 | 137.35 |
| 2024-12-26 | 137.82 |
| 2024-12-24 | 136.78 |
| 2024-12-23 | 137.25 |
| 2024-12-20 | 138.76 |
| 2024-12-19 | 135.94 |
| 2024-12-18 | 135.98 |
| 2024-12-17 | 139.42 |
| 2024-12-16 | 138.38 |
| 2024-12-13 | 142.62 |
| 2024-12-12 | 145.06 |
| 2024-12-11 | 145.81 |
| 2024-12-10 | 147.88 |
| 2024-12-09 | 149.81 |
| 2024-12-06 | 149.58 |
| 2024-12-05 | 150.05 |
| 2024-12-04 | 155.32 |
| 2024-12-03 | 155.83 |
| 2024-12-02 | 157.81 |
| 2024-11-29 | 158.56 |
| 2024-11-27 | 156.68 |
| 2024-11-26 | 154.61 |
| 2024-11-25 | 157.20 |
| 2024-11-22 | 156.21 |
| 2024-11-21 | 155.17 |
| 2024-11-20 | 153.48 |
| 2024-11-19 | 152.96 |
| 2024-11-18 | 155.32 |
| 2024-11-15 | 150.33 |
| 2024-11-14 | 149.11 |
| 2024-11-13 | 153.48 |
| 2024-11-12 | 159.13 |
| 2024-11-11 | 7.02 |
| 2024-11-08 | 7.11 |
| 2024-11-07 | 7.40 |
| 2024-11-06 | 7.41 |
| 2024-11-05 | 7.41 |
| 2024-11-04 | 7.35 |
| 2024-11-01 | 7.36 |
| 2024-10-31 | 7.33 |
| 2024-10-30 | 7.36 |
| 2024-10-29 | 7.39 |
| 2024-10-28 | 7.39 |
| 2024-10-25 | 7.38 |
| 2024-10-24 | 7.54 |
| 2024-10-23 | 7.48 |
| 2024-10-22 | 7.51 |
| 2024-10-21 | 7.51 |
| 2024-10-18 | 7.56 |
| 2024-10-17 | 7.52 |
| 2024-10-16 | 7.54 |
| 2024-10-15 | 7.52 |
| 2024-10-14 | 7.58 |
| 2024-10-11 | 7.50 |
| 2024-10-10 | 7.60 |
| 2024-10-09 | 7.77 |
| 2024-10-08 | 7.62 |
| 2024-10-07 | 7.34 |
| 2024-10-04 | 7.45 |
| 2024-10-03 | 7.20 |
| 2024-10-02 | 7.38 |
| 2024-10-01 | 7.58 |
| 2024-09-30 | 7.79 |
| 2024-09-27 | 7.99 |
| 2024-09-26 | 7.94 |
| 2024-09-25 | 7.87 |
| 2024-09-24 | 8.00 |
| 2024-09-23 | 8.00 |
| 2024-09-20 | 7.90 |
| 2024-09-19 | 7.95 |
| 2024-09-18 | 8.08 |
| 2024-09-17 | 8.17 |
| 2024-09-16 | 8.26 |
| 2024-09-13 | 8.15 |
| 2024-09-12 | 8.08 |
| 2024-09-11 | 8.06 |
| 2024-09-10 | 8.05 |
| 2024-09-09 | 8.05 |
| 2024-09-06 | 8.00 |
| 2024-09-05 | 7.97 |
| 2024-09-04 | 7.70 |
| 2024-09-03 | 7.77 |
| 2024-08-30 | 7.79 |
| 2024-08-29 | 7.83 |
| 2024-08-28 | 7.76 |
| 2024-08-27 | 7.78 |
| 2024-08-26 | 7.78 |
| 2024-08-23 | 7.70 |
| 2024-08-22 | 7.49 |
| 2024-08-21 | 7.43 |
| 2024-08-20 | 7.43 |
| 2024-08-19 | 7.48 |
| 2024-08-16 | 7.41 |
| 2024-08-15 | 7.33 |
| 2024-08-14 | 7.29 |
| 2024-08-13 | 7.08 |
| 2024-08-12 | 7.58 |
| 2024-08-09 | 7.62 |
| 2024-08-08 | 7.68 |
| 2024-08-07 | 7.51 |
| 2024-08-06 | 7.58 |
| 2024-08-05 | 6.66 |
| 2024-08-02 | 6.78 |
| 2024-08-01 | 6.92 |
| 2024-07-31 | 6.89 |
| 2024-07-30 | 6.90 |
| 2024-07-29 | 6.92 |
| 2024-07-26 | 6.83 |
| 2024-07-25 | 6.74 |
| 2024-07-24 | 6.82 |
| 2024-07-23 | 6.78 |
| 2024-07-22 | 6.80 |
| 2024-07-19 | 6.79 |
| 2024-07-18 | 6.86 |
| 2024-07-17 | 6.86 |
| 2024-07-16 | 6.83 |
| 2024-07-15 | 6.53 |
| 2024-07-12 | 6.79 |
| 2024-07-11 | 6.77 |
| 2024-07-10 | 6.58 |
| 2024-07-09 | 6.54 |
| 2024-07-08 | 6.46 |
| 2024-07-05 | 6.71 |
| 2024-07-03 | 6.37 |
| 2024-07-02 | 6.31 |
| 2024-07-01 | 6.35 |
| 2024-06-28 | 6.43 |
| 2024-06-27 | 6.44 |
| 2024-06-26 | 6.52 |
| 2024-06-25 | 6.53 |
| 2024-06-24 | 6.57 |
| 2024-06-21 | 6.59 |
| 2024-06-20 | 6.54 |
| 2024-06-18 | 6.48 |
| 2024-06-17 | 6.52 |
| 2024-06-14 | 6.49 |
| 2024-06-13 | 6.49 |
| 2024-06-12 | 6.40 |
| 2024-06-11 | 6.32 |
| 2024-06-10 | 6.32 |
| 2024-06-07 | 6.37 |
| 2024-06-06 | 6.40 |
| 2024-06-05 | 6.38 |
| 2024-06-04 | 6.40 |
| 2024-06-03 | 6.55 |
| 2024-05-31 | 6.55 |
| 2024-05-30 | 6.43 |
| 2024-05-29 | 6.38 |
| 2024-05-28 | 6.51 |
| 2024-05-24 | 6.52 |
| 2024-05-23 | 6.54 |
| 2024-05-22 | 6.60 |
| 2024-05-21 | 6.62 |
| 2024-05-20 | 6.73 |
| 2024-05-17 | 6.78 |
| 2024-05-16 | 6.76 |
| 2024-05-15 | 6.81 |
| 2024-05-14 | 6.77 |
| 2024-05-13 | 6.81 |
| 2024-05-10 | 6.86 |
| 2024-05-09 | 6.91 |
| 2024-05-08 | 6.87 |
| 2024-05-07 | 6.94 |
| 2024-05-06 | 7.02 |
| 2024-05-03 | 7.09 |
| 2024-05-02 | 7.09 |
| 2024-05-01 | 7.73 |
| 2024-04-30 | 7.73 |
| 2024-04-29 | 7.79 |
| 2024-04-26 | 7.69 |
| 2024-04-25 | 7.71 |
| 2024-04-24 | 7.84 |
| 2024-04-23 | 7.86 |
| 2024-04-22 | 7.74 |
| 2024-04-19 | 7.56 |
| 2024-04-18 | 7.60 |
| 2024-04-17 | 7.57 |
| 2024-04-16 | 7.58 |
| 2024-04-15 | 7.67 |
| 2024-04-12 | 7.73 |
| 2024-04-11 | 8.07 |
| 2024-04-10 | 8.05 |
| 2024-04-09 | 8.20 |
| 2024-04-08 | 8.09 |
| 2024-04-05 | 8.16 |
| 2024-04-04 | 8.17 |
| 2024-04-03 | 8.29 |
| 2024-04-02 | 8.22 |
| 2024-04-01 | 8.34 |
| 2024-03-28 | 8.19 |
| 2024-03-27 | 8.18 |
| 2024-03-26 | 7.96 |
| 2024-03-25 | 8.01 |
| 2024-03-22 | 8.03 |
| 2024-03-21 | 8.05 |
| 2024-03-20 | 8.01 |
| 2024-03-19 | 8.04 |
| 2024-03-18 | 7.96 |
| 2024-03-15 | 7.97 |
| 2024-03-14 | 8.05 |
| 2024-03-13 | 8.18 |
| 2024-03-12 | 8.22 |
| 2024-03-11 | 8.33 |
| 2024-03-08 | 8.39 |
| 2024-03-07 | 8.33 |
| 2024-03-06 | 8.24 |
| 2024-03-05 | 8.12 |
| 2024-03-04 | 8.14 |
| 2024-03-01 | 7.86 |
| 2024-02-29 | 7.84 |
| 2024-02-28 | 7.96 |
| 2024-02-27 | 8.02 |
| 2024-02-26 | 8.05 |
| 2024-02-23 | 8.15 |
| 2024-02-22 | 8.05 |
| 2024-02-21 | 8.09 |
| 2024-02-20 | 8.00 |
| 2024-02-16 | 7.90 |
| 2024-02-15 | 7.84 |
| 2024-02-14 | 7.59 |
| 2024-02-13 | 7.59 |
| 2024-02-12 | 7.72 |
| 2024-02-09 | 7.58 |
| 2024-02-08 | 7.75 |
| 2024-02-07 | 7.72 |
Showing the most recent 260 of 4,777 data points. The chart above shows the full history.
Related Metrics
About Baxter International Inc.
Baxter International Inc., operating globally via its subsidiaries, is a leading developer and provider of a wide spectrum of healthcare products. The company's comprehensive portfolio includes various dialysis treatments, such as peritoneal and hemodialysis, along with related therapies and services. It also specializes in intravenous (IV) therapies, infusion pumps, administration sets, and devices for drug reconstitution. Further expanding its pharmaceutical offerings, Baxter delivers pre-mixed and oncology drug platforms, inhaled anesthetic agents, critical care products, and pharmacy compounding services. Nutritional support is provided through its parenteral nutrition therapies and associated products. For surgical procedures, the company develops biological products and medical devices vital for achieving hemostasis, tissue sealing, and preventing adhesions. Additionally, Baxter supplies continuous renal replacement therapies (CRRT) and other organ support solutions, primarily tailored for intensive care units. Beyond direct medical supplies, Baxter provides sophisticated connected care solutions, integrating devices, software, communication systems, and other advanced technologies. This includes a range of patient monitoring and diagnostic technologies designed to aid in the diagnosis, treatment, and management of numerous illnesses and conditions, spanning respiratory therapy, cardiology, vision screening, and physical assessment. The surgical suite benefits from its specialized video technologies, operating tables, lights, pendants, precision positioning tools, and various ancillary accessories. The company also offers contracted services to a multitude of pharmaceutical and biopharmaceutical companies. Baxter's products are utilized across diverse healthcare environments, including hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and for home-based patients under medical supervision. Operating in approximately 100 countries, Baxter distributes its extensive product line through a direct sales force, independent distributors, drug wholesalers, and specialty pharmacies or other alternative site providers. The company also holds a collaborative agreement with Celerity Pharmaceutical, LLC, focused on developing generic injectable pre-mixed medications for acute care and oncolytic molecules. Established in 1931, Baxter International Inc. is headquartered in Deerfield, Illinois.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Andrew Hider